Market Overview

Benzinga's Top Upgrades

Share:
Related AMGN
Regeneron Is 'One Of The Stronger Growers In Biotech'
Stiff Biosimilar Headwinds To Negatively Impact Amgen's Aging Drug Portfolio
Strategic Dividend Dog Analysts Put MGA Tops For Summer (Seeking Alpha)
Related PCS
Is Wireless The New Cable?
Morgan Stanley Says Sprint's Headline EBITDA Should Be Strong

Piper Jaffray upgraded Amgen (NASDAQ: AMGN) from “neutral” to “overweight.” Amgen's shares closed at $79.29 yesterday. Amgen's trailing-twelve-month operating margin is 33.61%.

Deutsche Bank upgraded MetroPCS Communications (NYSE: PCS) from “hold” to “buy.” MetroPCS' stock closed at $8.59 yesterday. MetroPCS' trailing-twelve-month revenue is $4.93 billion.

Analysts at UBS upgraded Sprint Nextel (NYSE: S) from “neutral” to “buy.” Sprint's shares closed at $4.05 yesterday. Sprint had $7.57 billion in total cash for the latest quarter.

RW Baird upgraded AmerisourceBergen (NYSE: ABC) from “neutral” to “outperform.” AmerisourceBergen's shares closed at $37.96 yesterday. AmerisourceBergen's PEG ratio is 1.05.

Latest Ratings for AMGN

DateFirmActionFromTo
Jun 2016BernsteinInitiates Coverage onMarket Perform
Apr 2016BMO CapitalInitiates Coverage onOutperform
Feb 2016CitigroupInitiates Coverage onNeutral

View More Analyst Ratings for AMGN
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (AMGN + ABC)

View Comments and Join the Discussion!